View Future GrowthASP Isotopes 과거 순이익 실적과거 기준 점검 0/6ASP Isotopes 의 수입은 연평균 -80.3%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 1.4%의 비율로 증가했습니다. 매출은 연평균 122.4%의 비율로 증가해 왔습니다.핵심 정보-80.30%순이익 성장률-49.05%주당순이익(EPS) 성장률Chemicals 산업 성장률12.93%매출 성장률122.44%자기자본이익률-60.80%순이익률-734.17%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트ASP Isotopes Inc. to Report Q4, 2024 Results on Mar 31, 2025Mar 31모든 업데이트 보기Recent updatesASP Isotopes Inc. announced delayed annual 10-K filingApr 01Asp Isotopes Inc Completes Well Drilling Required for Phase 1 of Renergen Helium ProjectMar 23ASP Isotopes: Needs More Proof Mar 10New minor risk - Profitability Mar 09Executive Chairman & CEO notifies of intention to sell stock Mar 05Price target increased by 41% to US$12.00 Feb 14Forecast to breakeven in 2028 Feb 14ASP Isotopes Inc. Provides Production Update on the Renergen Helium ProjectJan 29ASP Isotopes Inc. Announces Executive AppointmentsJan 13ASP Isotopes Inc. (NasdaqCM:ASPI) completed the acquisition of Renergen Limited (JSE:REN) from Mazi Asset Management (Pty) Ltd, Matc Investments Pty Ltd, CRT investments Pty. Ltd., Anchor Capital (Pty) Ltd., Ivy Asset Management LLC, Ye Jia and others.Jan 07Asp Isotopes Inc. Announces That Paul Mann to Return from Temporary Leave of Absence as Executive ChairmanDec 03Asp Isotopes Inc. Announces Paul Mann to Return from Temporary Leave of Absence as Chief Executive Officer, Effective January 19, 2026Dec 02ASP Isotopes Inc., Annual General Meeting, Dec 18, 2025Nov 26ASP Isotopes Inc. announced delayed 10-Q filingNov 15COO & Interim CEO notifies of intention to sell stock Oct 18ASP Isotopes Inc. has completed a Follow-on Equity Offering in the amount of $210.3 million.Oct 15+ 1 more updateIndependent Director notifies of intention to sell stock Oct 02ASP Isotopes Inc. Announces Paul Mann Becomes Executive Chairman, Effective October 1, 2025Sep 30Consensus revenue estimates fall by 32% Sep 18President notifies of intention to sell stock Sep 11Asp Isotopes Inc. Appoints Ralph Hunter to Board of Directors, Effective as of September 8, 2025Sep 08Independent Director notifies of intention to sell stock Aug 31Price target increased by 29% to US$11.00 Aug 15ASP Isotopes Inc. has filed a Follow-on Equity Offering in the amount of $60 million.Jul 24ASP Isotopes Inc. Announces Updates on the Progress of Commercial Production At Its Three Enrichment Facilities in South AfricaJul 17ASP Isotopes Inc. has filed a Follow-on Equity Offering in the amount of $50 million.Jun 03ASP Isotopes Inc. (NasdaqCM:ASPI) entered into agreement to acquire Renergen Limited (JSE:REN) from Mazi Asset Management (Pty) Ltd, Matc Investments Pty Ltd, CRT investments Pty. Ltd., Anchor Capital (Pty) Ltd., Ivy Asset Management LLC, Ye Jia and others.May 21ASP Isotopes Inc. announced delayed 10-Q filingMay 16ASP Isotopes Inc. has filed a Follow-on Equity Offering in the amount of $25 million.May 01President notifies of intention to sell stock Apr 17ASP Isotopes Inc. Announces Board ChangesApr 16Asp Isotopes Inc. Completes Commissioning of First Quantum Enrichment Laser System and Starts Production of Commercial Samples of Ytterbium-176Apr 01ASP Isotopes Inc. to Report Q4, 2024 Results on Mar 31, 2025Mar 31Asp Isotopes Inc. Commences Commercial Production of Enriched Silicon-28 At Its Second Aerodynamic Separation Process (Asp) Enrichment FacilityMar 27Asp Isotopes Inc. Commences Commercial Production of Enriched Carbon-14 At Its First Aerodynamic Separation Process (Asp) Enrichment FacilityFeb 26Price target increased by 18% to US$6.50 Feb 14Forecast to breakeven in 2026 Feb 14ASP Isotopes: Too Hot To Handle Jan 25Asp Isotopes Inc Announces Filing of Class Action LawsuitDec 05ASP Isotopes Inc. announced delayed 10-Q filingNov 15Forecast to breakeven in 2026 Nov 14ASP Isotopes Inc. has completed a Follow-on Equity Offering in the amount of $16.16625 million.Nov 02ASP Isotopes Inc. has filed a Follow-on Equity Offering.Nov 01ASP Isotopes Inc., Annual General Meeting, Nov 20, 2024Oct 22ASP Isotopes Inc. Enriches Ytterbium-176 During Commissioning Phase of First Quantum Enrichment FacilityOct 17ASP Isotopes Inc. announced delayed 10-Q filingAug 15New major risk - Shareholder dilution Jul 14ASP Isotopes Inc. has filed a Follow-on Equity Offering.Jul 13+ 1 more updateHigh number of new and inexperienced directors Jun 29ASP Isotopes Inc. Appoints Heather Kiessling as Its Chief Financial Officer, Effective as of July 1, 2024Jun 16ASP Isotopes Inc. announced delayed annual 10-K filingMar 30ASP Isotopes Inc. announced that it expects to receive $20 million in fundingFeb 19ASP Isotopes Inc. Announces Board ChangesJan 19High number of new and inexperienced directors Dec 31ASP Isotopes Inc. Announces Executive ChangesOct 20ASP Isotopes Inc. announced that it expects to receive $8.1945 million in funding from Tees River Critical Resources Fund LimitedOct 11Forecast to breakeven in 2024 Aug 15ASP Isotopes Inc. announced delayed 10-Q filingMay 16ASP Isotopes Receives Non-Compliance Notice From NasdaqMay 11ASP Isotopes Inc. has completed an IPO in the amount of $5 million.Nov 11매출 및 비용 세부 내역ASP Isotopes가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이NasdaqCM:ASPI 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비31 Dec 2524-175481230 Sep 258-10638730 Jun 255-10030531 Mar 254-3726431 Dec 244-3525330 Sep 243-3022230 Jun 242-2721131 Mar 241-2018131 Dec 230-1615130 Sep 230-1313130 Jun 230-1110131 Mar 230-87131 Dec 220-541양질의 수익: ASPI 은(는) 현재 수익성이 없습니다.이익 마진 증가: ASPI는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: ASPI은 수익성이 없으며 지난 5년 동안 손실이 연평균 80.3% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 ASPI의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: ASPI은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(0.1%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: ASPI는 현재 수익성이 없으므로 자본 수익률이 음수(-60.8%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/03 14:13종가2026/05/01 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스ASP Isotopes Inc.는 4명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관George GianarikasCanaccord Genuitynull nullCantor Fitzgerald & Co.Derek SoderbergCantor Fitzgerald & Co.1명의 분석가 더 보기
ASP Isotopes Inc. (NasdaqCM:ASPI) completed the acquisition of Renergen Limited (JSE:REN) from Mazi Asset Management (Pty) Ltd, Matc Investments Pty Ltd, CRT investments Pty. Ltd., Anchor Capital (Pty) Ltd., Ivy Asset Management LLC, Ye Jia and others.Jan 07
Asp Isotopes Inc. Announces That Paul Mann to Return from Temporary Leave of Absence as Executive ChairmanDec 03
Asp Isotopes Inc. Announces Paul Mann to Return from Temporary Leave of Absence as Chief Executive Officer, Effective January 19, 2026Dec 02
ASP Isotopes Inc. has completed a Follow-on Equity Offering in the amount of $210.3 million.Oct 15+ 1 more update
Asp Isotopes Inc. Appoints Ralph Hunter to Board of Directors, Effective as of September 8, 2025Sep 08
ASP Isotopes Inc. Announces Updates on the Progress of Commercial Production At Its Three Enrichment Facilities in South AfricaJul 17
ASP Isotopes Inc. (NasdaqCM:ASPI) entered into agreement to acquire Renergen Limited (JSE:REN) from Mazi Asset Management (Pty) Ltd, Matc Investments Pty Ltd, CRT investments Pty. Ltd., Anchor Capital (Pty) Ltd., Ivy Asset Management LLC, Ye Jia and others.May 21
Asp Isotopes Inc. Completes Commissioning of First Quantum Enrichment Laser System and Starts Production of Commercial Samples of Ytterbium-176Apr 01
Asp Isotopes Inc. Commences Commercial Production of Enriched Silicon-28 At Its Second Aerodynamic Separation Process (Asp) Enrichment FacilityMar 27
Asp Isotopes Inc. Commences Commercial Production of Enriched Carbon-14 At Its First Aerodynamic Separation Process (Asp) Enrichment FacilityFeb 26
ASP Isotopes Inc. has completed a Follow-on Equity Offering in the amount of $16.16625 million.Nov 02
ASP Isotopes Inc. Enriches Ytterbium-176 During Commissioning Phase of First Quantum Enrichment FacilityOct 17
ASP Isotopes Inc. Appoints Heather Kiessling as Its Chief Financial Officer, Effective as of July 1, 2024Jun 16
ASP Isotopes Inc. announced that it expects to receive $8.1945 million in funding from Tees River Critical Resources Fund LimitedOct 11